 | Ritonavir, sold under the brand name Norvir, is an antiretroviral medication used along with other medications to treat HIV/AIDS. This combination treatment... 41 KB (3,407 words) - 13:51, 21 January 2024 |
 | Nirmatrelvir/ritonavir, sold under the brand name Paxlovid, is a co-packaged medication used as a treatment for COVID‑19. It contains the antiviral medications... 64 KB (5,751 words) - 07:52, 24 March 2024 |
 | Lopinavir/ritonavir (LPV/r), sold under the brand name Kaletra among others, is a fixed-dose combination antiretroviral medication for the treatment and... 19 KB (1,540 words) - 19:28, 20 December 2023 |
 | Simnotrelvir/ritonavir (trade name Xiannuoxin) is a pharmaceutical drug used for the treatment of COVID-19. Simnotrelvir/ritonavir is a combination drug... 8 KB (332 words) - 07:36, 11 February 2024 |
Atazanavir/ritonavir (ATV/r) is a fixed-dose combination antiretroviral medication used in the treatment of HIV/AIDS. It combines atazanavir and ritonavir. It... 4 KB (213 words) - 23:28, 25 July 2023 |
Ombitasvir/paritaprevir/ritonavir, sold under the brand name Technivie among others, is a medication used to treat hepatitis C. It is a fixed-dose combination... 18 KB (1,456 words) - 19:28, 20 December 2023 |
Amprenavir Atazanavir Darunavir Fosamprenavir Indinavir Lopinavir Nelfinavir Ritonavir Saquinavir Tipranavir Hepatitis C virus NS3/4A protease inhibitors—class... 15 KB (1,168 words) - 04:21, 24 December 2023 |
 | interact with strong CYP3A4 inhibitors such as ritonavir and ketoconazole. Coadministration of ritonavir and fluticasone may lead to increased levels of... 17 KB (1,036 words) - 04:19, 14 April 2024 |
| orally active 3C-like protease inhibitor. It is part of a nirmatrelvir/ritonavir combination used to treat COVID-19 and sold under the brand name Paxlovid... 24 KB (1,910 words) - 17:27, 25 February 2024 |
 | medications to treat or prevent HIV/AIDS. Typically it is used with ritonavir or lopinavir/ritonavir to increase its effect. It is taken by mouth. Common side effects... 16 KB (1,116 words) - 19:41, 20 December 2023 |
 | the inhibition of human CYP3A proteins.[non-primary source needed] Like ritonavir (Norvir), cobicistat is of interest for its ability to inhibit liver enzymes... 11 KB (906 words) - 07:14, 14 March 2024 |
AbbVie to license its patents for Kaletra, the brand name of lopinavir/ritonavir, a fixed dose combination medication for the treatment and prevention... 39 KB (3,320 words) - 09:02, 14 April 2024 |
 | form crystals with its own form. One example is the anti-AIDS medicine ritonavir, where the newer polymorph destroyed the effectiveness of the drug until... 9 KB (1,168 words) - 09:07, 18 April 2024 |
 | antiviral protease inhibitor, Paxlovid (nirmatrelvir plus the HIV antiviral ritonavir), to treat adult patients. FDA later gave it an EUA. Most cases of COVID-19... 372 KB (32,316 words) - 04:26, 25 April 2024 |
Foscarnet J05AD02 Fosfonet J05AE01 Saquinavir J05AE02 Indinavir J05AE03 Ritonavir J05AE04 Nelfinavir J05AE05 Amprenavir J05AE07 Fosamprenavir J05AE08 Atazanavir... 6 KB (538 words) - 04:59, 18 December 2023 |
 | following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137". J. Acquir. Immune Defic. Syndr. 45 (3): 274–9. doi:10... 28 KB (2,304 words) - 23:29, 30 March 2024 |
 | as a fixed-dose combination with another protease inhibitor, ritonavir (lopinavir/ritonavir). It was patented in 1995 and approved for medical use in 2000... 9 KB (699 words) - 08:13, 19 February 2024 |
Efavirenz Nevirapine Atazanavir/ritonavir (atazanavir + ritonavir) Darunavir Lopinavir/ritonavir (lopinavir + ritonavir) Ritonavir Dolutegravir Raltegravir Abacavir/lamivudine... 77 KB (4,835 words) - 05:22, 23 March 2024 |
 | Niaspan); Specific HIV protease inhibitors such as: lopinavir and ritonavir (Kaletra), and ritonavir (Norvir) taken with darunavir (Prezista); and spironolactone... 15 KB (1,269 words) - 12:43, 20 January 2024 |
Crystal polymorphism (section Ritonavir) added to the Cambridge Structural Database (CSD). The antiviral drug ritonavir exists as two polymorphs, which differ greatly in efficacy. Such issues... 46 KB (4,920 words) - 16:41, 7 April 2024 |
 | hydrocodone/acetaminophen with the antiviral regimen of ombitasvir, paritaprevir, ritonavir, and dasabuvir for treatment of hepatitis C increased peak concentrations... 53 KB (4,924 words) - 15:56, 18 March 2024 |
 | inter-individual variability in its half-life and potency. Ritonavir or lopinavir/ritonavir greatly increase plasma concentrations of oxycodone in healthy... 122 KB (11,214 words) - 15:24, 20 April 2024 |
paritaprevir, ritonavir and dasabuvir in the product Viekira Pak for the treatment of HCV genotype 1, and with paritaprevir and ritonavir in the product... 6 KB (360 words) - 11:46, 12 December 2023 |
 | protease inhibitors including atazanavir (when taken with ritonavir), lopinavir/ritonavir and simeprevir Alcohol intake should be reduced while on rosuvastatin... 40 KB (3,377 words) - 16:54, 30 January 2024 |
and safety evaluation of high-dose combinations of fosamprenavir and ritonavir". Antimicrobial Agents and Chemotherapy. 50 (3): 928–934. doi:10.1128/AAC... 16 KB (1,519 words) - 23:27, 1 April 2024 |
 | elvitegravir boosted by ritonavir had greater reductions in viral load after 24 weeks compared to individuals randomized to receive a ritonavir-boosted protease... 10 KB (849 words) - 11:30, 7 November 2023 |
 | Reserpine Reverse triiodothyronine Rifampicin Rifaximin Rimexolone Riodipine Ritonavir Simvastatin Sirolimus Spironolactone Spiroxatrine SR-12813 Suberoylanilide... 41 KB (3,747 words) - 03:31, 19 February 2024 |
 | nirmatrelvir/ritonavir (developed by Pfizer). Others were thought to be promising early in the pandemic, such as hydroxychloroquine and lopinavir/ritonavir, but... 285 KB (32,669 words) - 05:08, 20 April 2024 |
Nirmatrelvir/ritonavir (Paxlovid) COVID-19 Pfizer 3C-like protease inhibitor (Nirmatrelvir) / inhibition of metabolism of nirmatrelvir (ritonavir) Nevirapine... 13 KB (513 words) - 21:21, 8 March 2024 |
 | medications nirmatrelvir and ritonavir and was developed by Pfizer. Nirmatrelvir inhibits SARS-CoV-2 main protease, while ritonavir is a strong CYP3A inhibitor... 90 KB (13,106 words) - 20:17, 24 March 2024 |